Drug
Jtk 853
Jtk 853: highest development phase Phase 1, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| JTK-853 NCT01473056 | Phase 1 | Hepatitis C Virus Infection, Response to Therapy of |
Latest
No recent events.
Follow Jtk 853 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.